In order to further investigate potential activation mechanisms of Orai1 involved in the development of breast cancer, biotinylated Orai1-NT or CT peptides were synthesized, and a biotin-based pull-down assay was performed to identify the proteins interacting with Orai1. Here, ORAI1 is linked to breast carcinoma.